US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

54.07

+0.60001.12%

Post-market: 54.070.00000.00%16:10 EDT

Volume:115.73K

Turnover:6.22M

Market Cap:1.84B

PE:11.06

High:54.29

Open:53.72

Low:53.17

Close:53.47

52wk High:54.29

52wk Low:39.58

Shares:34.00M

Float Shares:27.67M

Volume Ratio:2.01

T/O Rate:0.42%

Dividend:3.06

Dividend Rate:5.65%

EPS(TTM):4.89

EPS(LYR):2.11

ROE:27.21%

ROA:5.25%

PB:2.74

PE(LYR):25.63

Loading ...

Overview Company News Filings

Global Partners Lp Q1 Operating Income USD 105.739 Million

THOMSON REUTERS

Voyager Reports First Quarter 2026 Financial and Operating Results

Wegovy pill saw the fastest take-up since the advent of GLP-1 drugs

Editas Medicine Announces First Quarter 2026 Results and Business Updates

Does Global Partners' (GLP) Steady Distribution Reveal Enduring Value Or Mask Shifting Risks?

Simply Wall St.

Structure Therapeutics (GPCR) Is Down 7.2% After Strong Phase 2 Oral GLP‑1 Obesity Data – Has The Bull Case Changed?

Simply Wall St.

Can GLP-1s curb alcohol use? A new study says the drugs can reduce heavy drinking.

Earning Preview: Global Partners LP this quarter’s revenue is expected to increase by 23.69%, and institutional views are mixed

Press Release: Global Partners Declares First-Quarter 2026 Cash Distribution of $0.7650 on Common Units

Loblaw Earns Buy Rating on Strong Earnings Momentum, Market Share Gains and GLP‑1 Growth Tailwinds

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

A Look At Insulet (PODD) Valuation After Device Correction And Growing GLP-1 Competition Concerns

Simply Wall St.

ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

Wedding Dresses Now Come With a Legal Waiver for Brides on GLP-1s -- WSJ

Is It Time To Reassess Global Partners (GLP) After Recent Energy Sector Coverage?

Simply Wall St.

Global Partners schedules first-quarter results conference call

Domestic Long-Acting GLP-1 Drug Tops 100 Million Yuan in First-Year Sales but Faces Deepening Losses

โมเดลการดูแลแบบผสมผสานของ NOVI Health ช่วยปิดช่องว่างระหว่างผลลัพธ์การทดลองทางคลินิกกับผลลัพธ์การใช้จริงของยา GLP-1

NOVI Health's Hybrid Care Model Closes Gap Between Clinical Trials and Real-World GLP-1 Outcomes

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/GLP/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners LP","latestPrice":54.07,"timestamp":1789070400000,"preClose":53.47,"halted":0,"volume":115725,"hourTrading":{"tag":"盘后","latestPrice":54.07,"preClose":54.07,"latestTime":"16:10 EDT","volume":2209,"amount":119440.63,"timestamp":1789071008187,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011221245558256994,"floatShares":27674174,"shares":33995563,"eps":4.887034,"marketStatus":"Post-Mkt","change":0.6,"latestTime":"09-10 16:12:02 EDT","open":53.72,"high":54.29,"low":53.17,"amount":6221612.889075,"amplitude":0.020946,"askPrice":55.12,"askSize":36,"bidPrice":53.32,"bidSize":1,"shortable":3,"etf":0,"ttmEps":4.887034,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":53.47,"dividendRate":0.056501,"preHourTrading":{"tag":"盘前","latestPrice":52.89,"preClose":53.47,"latestTime":"09:01 EDT","volume":42,"amount":2265.959934,"timestamp":1789045291208,"change":-0.58,"changeRate":-0.010847,"amplitude":0.020572},"postHourTrading":{"tag":"盘后","latestPrice":54.07,"preClose":54.07,"latestTime":"16:10 EDT","volume":2209,"amount":119440.63,"timestamp":1789071008187,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.013905,"impliedVol":0.2332,"impliedVolPercentile":0.1673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"5.25%","roe":"27.21%","lyrEps":2.11,"volumeRatio":2.013905,"shares":33995563,"dividePrice":3.055,"high":54.29,"amplitude":0.020946,"preClose":53.47,"low":53.17,"week52Low":39.58,"pbRate":"2.74","psRate":"0.09","week52High":54.29,"institutionHeld":0.4978,"latestPrice":54.07,"committee":-0.945946,"eps":4.887034,"divideRate":0.056501,"volume":115725,"delay":0,"ttmEps":4.887034,"open":53.72,"prevYearClose":41.85,"prevWeekClose":52.7,"prevMonthClose":51.35,"prevQuarterClose":46.59,"fiveDayClose":52.59,"twentyDayClose":50.8,"sixtyDayClose":45.61,"dividendPayoutRate":1.4047537053315338,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":0.045454545454545574,"fiveYearAvgDividendRate":0.07675548971847668},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"GLP","amount":0.78,"announcedDate":"2026-07-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-10","defaultRemindTime":1786368600000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-08-10","currency":"USD","dateTimestamp":1786334400000,"payDate":"2026-08-14"},{"market":"US","date":"2026-08-07","symbol":"GLP","fiscalQuarterEnding":"2026/06","expectedEps":1.24,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":1.86},{"date":"2026-05-11","symbol":"GLP","amount":0.765,"announcedDate":"2026-04-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-11","defaultRemindTime":1778506200000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-15","payableDate":"2026-05-11","currency":"USD","dateTimestamp":1778472000000,"payDate":"2026-05-15"},{"market":"US","date":"2026-05-08","symbol":"GLP","fiscalQuarterEnding":"2026/03","expectedEps":0.33,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":1.85},{"market":"US","date":"2026-02-27","symbol":"GLP","fiscalQuarterEnding":"2025/12","expectedEps":0.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"pre","actualEps":0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-05-08","recordDate":"2017-05-10","paymentDate":"2017-05-15","value":0.4625,"currency":"USD"},{"executeDate":"2017-08-07","recordDate":"2017-08-09","paymentDate":"2017-08-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-11-08","recordDate":"2017-11-09","paymentDate":"2017-11-14","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2026-09-09","current":10.941197,"percent":0.340032,"low":2.771386,"twenty":4.430278,"median":13.224197,"eighty":18.296138,"high":29.252017,"avg":12.510952,"sd":6.325875,"marketCap":1797719274},"quantilePoints":[{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540},{"date":"2025-11-21","current":18.438808,"twenty":4.440923,"median":10.856288,"eighty":16.560326,"marketCap":1450451976},{"date":"2025-11-28","current":18.911819,"twenty":4.440923,"median":10.868211,"eighty":16.63112,"marketCap":1487660399},{"date":"2025-12-05","current":19.647135,"twenty":4.440923,"median":10.912667,"eighty":16.757487,"marketCap":1545502583},{"date":"2025-12-12","current":19.023621,"twenty":4.440923,"median":10.960835,"eighty":17.137473,"marketCap":1496455117},{"date":"2025-12-19","current":18.228104,"twenty":4.440923,"median":11.01485,"eighty":17.334253,"marketCap":1433877315},{"date":"2025-12-26","current":18.425908,"twenty":4.440923,"median":11.091519,"eighty":17.554114,"marketCap":1449437201},{"date":"2026-01-02","current":17.995898,"twenty":4.440923,"median":11.134288,"eighty":17.640744,"marketCap":1415611362},{"date":"2026-01-09","current":18.017399,"twenty":4.440923,"median":11.163158,"eighty":17.676428,"marketCap":1417302654},{"date":"2026-01-16","current":19.488032,"twenty":4.440923,"median":11.24834,"eighty":17.766657,"marketCap":1532987023},{"date":"2026-01-23","current":19.139724,"twenty":4.440923,"median":11.32675,"eighty":17.850054,"marketCap":1505588093},{"date":"2026-01-30","current":20.571656,"twenty":4.440923,"median":11.753419,"eighty":17.910997,"marketCap":1618228137},{"date":"2026-02-06","current":20.33085,"twenty":4.440923,"median":12.428533,"eighty":17.953744,"marketCap":1599285667},{"date":"2026-02-13","current":20.812461,"twenty":4.440923,"median":12.525152,"eighty":17.974678,"marketCap":1637170607},{"date":"2026-02-20","current":20.851162,"twenty":4.440923,"median":12.588448,"eighty":17.999212,"marketCap":1640214933},{"date":"2026-02-27","current":20.799561,"twenty":4.440923,"median":12.709526,"eighty":18.067895,"marketCap":1636155832},{"date":"2026-03-06","current":20.672279,"twenty":4.440923,"median":12.766265,"eighty":18.127559,"marketCap":1637616565},{"date":"2026-03-13","current":20.301456,"twenty":4.440923,"median":12.901358,"eighty":18.151279,"marketCap":1608240762},{"date":"2026-03-20","current":20.668016,"twenty":4.440923,"median":12.995923,"eighty":18.186283,"marketCap":1637278912},{"date":"2026-03-27","current":19.180465,"twenty":4.440923,"median":13.141823,"eighty":18.229004,"marketCap":1519438050},{"date":"2026-04-02","current":18.703084,"twenty":4.440923,"median":13.196601,"eighty":18.240144,"marketCap":1481620925},{"date":"2026-04-10","current":19.640796,"twenty":4.440923,"median":13.260704,"eighty":18.317083,"marketCap":1555904563},{"date":"2026-04-17","current":19.291285,"twenty":4.440923,"median":13.316341,"eighty":18.347375,"marketCap":1528217025},{"date":"2026-04-24","current":20.105389,"twenty":4.440923,"median":13.379586,"eighty":18.414049,"marketCap":1592708729},{"date":"2026-05-01","current":20.561458,"twenty":4.440923,"median":13.473893,"eighty":18.438773,"marketCap":1628837589},{"date":"2026-05-08","current":20.352604,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1612292597},{"date":"2026-05-15","current":12.885011,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1671044202},{"date":"2026-05-22","current":13.165365,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1707403066},{"date":"2026-05-29","current":12.599564,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1634024821},{"date":"2026-06-05","current":12.971526,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1682264223},{"date":"2026-06-12","current":13.002959,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1686340792},{"date":"2026-06-18","current":11.368421,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1474359194},{"date":"2026-06-26","current":12.096629,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1568799713},{"date":"2026-07-02","current":12.418822,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1610584548},{"date":"2026-07-10","current":12.581228,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1631646822},{"date":"2026-07-17","current":12.793403,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1659163664},{"date":"2026-07-24","current":12.657192,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1641498531},{"date":"2026-07-31","current":12.827456,"twenty":4.430278,"median":13.61218,"eighty":18.497515,"marketCap":1663579947},{"date":"2026-08-07","current":12.709581,"twenty":4.430278,"median":13.586443,"eighty":18.488123,"marketCap":1648292813},{"date":"2026-08-14","current":9.682351,"twenty":4.430278,"median":13.533763,"eighty":18.438669,"marketCap":1686694623},{"date":"2026-08-21","current":9.826139,"twenty":4.430278,"median":13.385664,"eighty":18.409105,"marketCap":1711742868},{"date":"2026-08-28","current":9.793107,"twenty":4.430278,"median":13.322719,"eighty":18.34398,"marketCap":1705988541},{"date":"2026-09-04","current":10.197267,"twenty":4.430278,"median":13.275377,"eighty":18.311625,"marketCap":1776394417},{"date":"2026-09-09","current":10.31968,"twenty":4.430278,"median":13.224197,"eighty":18.296138,"marketCap":1797719274}],"updateTime":1789045992180},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633845555","title":"Global Partners Lp Q1 Operating Income USD 105.739 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633845555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633845555?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLX49CEC9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4590","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633176454","title":"Voyager Reports First Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633176454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633176454?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:01","pubTimestamp":1778184060,"startTime":"0","endTime":"0","summary":"- VY1706 and NBIB-‘233 completed IND-enabling GLP toxicology; clinical entry expected H2 2026 - - Multiple presentations at ASGCT 2026, including late breaker on VY1706 3-month GLP tox data - - Ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290505/36461/en/Voyager-Reports-First-Quarter-2026-Financial-and-Operating-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","AD","GLP","FA","BK4144","BK4590","BK4130","BK4132","IND","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633902809","title":"Wegovy pill saw the fastest take-up since the advent of GLP-1 drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2633902809","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633902809?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:44","pubTimestamp":1778053440,"startTime":"0","endTime":"0","summary":"This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633774914","title":"Editas Medicine Announces First Quarter 2026 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633774914","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633774914?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":"EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, on track to achieve early human proof-of-concept data by year-end 2026 Company to present new EDIT-401 preclinical data a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3287494/0/en/Editas-Medicine-Announces-First-Quarter-2026-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT","BK4556","BK4590","BK4139","BK4588","LU1861559042.SGD","LU1861558580.USD","BK4144","BK4611","CRSP","GLP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632715959","title":"Does Global Partners' (GLP) Steady Distribution Reveal Enduring Value Or Mask Shifting Risks?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632715959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632715959?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:25","pubTimestamp":1777904745,"startTime":"0","endTime":"0","summary":"Global Partners LP previously declared a first-quarter 2026 cash distribution of US$0.7650 per common unit, payable on May 15, 2026 to unitholders of record as of May 11, 2026, with non-U.S. investors subject to enhanced U.S. federal income tax withholding through their brokers.\nThe maintained payout level and focus on regular cash returns, alongside external views that the units may be attractively valued, highlight how income and value considerations are central to the Global Partners...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/does-global-partners-glp-steady-distribution-reveal-enduring","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/does-global-partners-glp-steady-distribution-reveal-enduring","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4590","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632002966","title":"Structure Therapeutics (GPCR) Is Down 7.2% After Strong Phase 2 Oral GLP‑1 Obesity Data – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632002966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632002966?lang=en_us&edition=fundamental","pubTime":"2026-05-03 22:18","pubTimestamp":1777817901,"startTime":"0","endTime":"0","summary":"Structure Therapeutics previously reported encouraging Phase 2 ACCESS II trial results for its oral GLP-1 receptor agonist aleniglipron, showing up to 16.3% weight reduction in adults with obesity and outlining plans to meet the FDA in Q2 2026 ahead of Phase 3 trials in the second half of 2026.\nThe data position aleniglipron as one of the most effective oral GLP-1 candidates so far, highlighting a potentially meaningful differentiation versus other pill-based obesity treatments.\nNext, we...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/structure-therapeutics-gpcr-is-down-72-after-strong-phase-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/structure-therapeutics-gpcr-is-down-72-after-strong-phase-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4590","GLP","BK4599","GPCR","BK4007","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632610547","title":"Can GLP-1s curb alcohol use? A new study says the drugs can reduce heavy drinking.","url":"https://stock-news.laohu8.com/highlight/detail?id=2632610547","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632610547?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:57","pubTimestamp":1777643820,"startTime":"0","endTime":"0","summary":"A new study says the drugs can reduce heavy drinking.A 'gold standard' trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for alcohol-use disorder. A new study found that taking Novo Nordisk's semaglutide, which is marketed under the names Ozempic and Wegovy, helped reduce heavy drinking in people with alcohol-use disorder.A GLP-1 medication helped people with obesity who were undergoing treatment for alcohol-use disorder drink less, according to new research.The study, which was published Friday in The Lancet, evaluated a once-weekly shot of semaglutide, the Novo Nordisk drug marketed as Ozempic and Wegovy, for about six months. It found that taking the drug was associated with a reduction in \"heavy drinking days,\" which is defined as five or more daily drinks for men and four or more daily drinks for women, compared with subjects who received a saline placebo, in the 88 people in Denmark who completed the study.Novo's U.S.-listed share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJJMRX11.SGD","IE00BKVL7J92.USD","LU0097036916.USD","LU0964807845.USD","NVOX","LU0689472784.USD","SG9999014914.USD","LU2271345857.HKD","ELIS","LLY","SGXZ51526630.SGD","GLP","LU0823434740.USD","LU0385154629.USD","LU0114720955.EUR","BK4599","LU1069344957.HKD","LU0096364046.USD","LLII","BK4516","LU0708995401.HKD","LU1023059063.AUD","NVOH","LU0432979614.USD","LU0466842654.USD","LU0203202063.USD","LU0133085943.USD","LU0320765059.SGD","LU2324357040.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU1804176565.USD","LU2357305700.SGD","LU0203201768.USD","LU0225283273.USD","LU0683600562.USD","LU2063271972.USD","LU2471134796.USD","IE00BN29S564.USD","NVO","LLYZ","LU2168564065.EUR","LLYX","IE00BKDWB100.SGD","GB00BDT5M118.USD","IE0004445239.USD","LU2168564495.EUR","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158233601","title":"Earning Preview: Global Partners LP this quarter’s revenue is expected to increase by 23.69%, and institutional views are mixed","url":"https://stock-news.laohu8.com/highlight/detail?id=1158233601","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158233601?lang=en_us&edition=fundamental","pubTime":"2026-05-01 10:09","pubTimestamp":1777601384,"startTime":"0","endTime":"0","summary":"Abstract Global Partners LP is scheduled to release its quarterly results on May 8, 2026 Pre-Market, and this preview reviews last quarter’s performance, synthesizes quantitative expectations for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Global Partners LP this quarter’s revenue is expected to increase by 23.69%, and institutional views are mixed","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631329236","title":"Press Release: Global Partners Declares First-Quarter 2026 Cash Distribution of $0.7650 on Common Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2631329236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631329236?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:30","pubTimestamp":1777552200,"startTime":"0","endTime":"0","summary":"Global Partners LP   today announced that the Board of Directors of its general partner, Global GP LLC, has declared a cash distribution of $0.7650 per unit  on all of its outstanding common units for the period from January 1, 2026 through March 31, 2026. The distribution will be paid on May 15, 2026 to unitholders of record as of the close of business on May 11, 2026.Global Partners, a master limited partnership, trades on the New York Stock Exchange under the ticker symbol \"GLP.\" For additional information, visit www.globalp.com.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631686959","title":"Loblaw Earns Buy Rating on Strong Earnings Momentum, Market Share Gains and GLP‑1 Growth Tailwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2631686959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631686959?lang=en_us&edition=fundamental","pubTime":"2026-04-30 16:36","pubTimestamp":1777538162,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Michael Van Aelst from TD Cowen maintained a Buy rating on Loblaw Companies, with a price target of C$75.00. Michae...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/loblaw-earns-buy-rating-on-strong-earnings-momentum-market-share-gains-and-glp‑1-growth-tailwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/loblaw-earns-buy-rating-on-strong-earnings-momentum-market-share-gains-and-glp‑1-growth-tailwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630108233","title":"Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2630108233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630108233?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:31","pubTimestamp":1777321860,"startTime":"0","endTime":"0","summary":"- Late-breaking oral presentation: IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month GLP toxicology study in NHPs - - Additio","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3282064/36461/en/Voyager-IV-Delivered-CNS-Gene-Therapies-Featured-in-Multiple-Presentations-at-ASGCT-2026-Including-Late-Breaker-on-Tau-Targeted-VY1706-for-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4590","IND","BK4144","GLP","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630363343","title":"A Look At Insulet (PODD) Valuation After Device Correction And Growing GLP-1 Competition Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2630363343","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630363343?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:08","pubTimestamp":1777320508,"startTime":"0","endTime":"0","summary":"Why Insulet’s recent device correction and mixed sentiment matter for investors\nInsulet (PODD) is back in focus after a voluntary Medical Device Correction for certain Omnipod 5 pod lots, mixed analyst reactions, and louder commentary about GLP-1 competition and future growth potential.\nSee our latest analysis for Insulet.\nRecent headlines, including the Omnipod 5 device correction, mixed commentary on GLP-1 competition, and updated earnings guidance, have coincided with weaker momentum, with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/a-look-at-insulet-podd-valuation-after-device-correction-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/a-look-at-insulet-podd-valuation-after-device-correction-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","LU1084165304.USD","BK4590","LU1119994496.HKD","LU2324357040.USD","BK4588","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","BK4566","PODD","BK4551","BK4144","LU2065170008.USD","BK4585","LU1261432733.SGD","GLP","LU0728928796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164887151","title":"ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164887151","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164887151?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:12","pubTimestamp":1777248751,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced that patient enrollment has been completed for its 13-week US Phase II clinical study (NCT07321678) evaluating the oral small-molecule GLP-1 receptor agonist ASC30...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK1574","BK1161","01672","01477","BK1191","BK1515","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630701332","title":"Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2630701332","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630701332?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:10","pubTimestamp":1777248600,"startTime":"0","endTime":"0","summary":"- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes.- Topline data from the Phase II study are expected in the third quarter of 2026.The Phase II study is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 tablets in participants with type 2 diabetes mellitus. The primary endpoint of the Phase II study is the mean change from baseline in HbA1c up to 13 weeks in the treatment group compared with the placebo group. Secondary endpoints include the mean change from baseline in fasting blood glucose up to 13 weeks in the treatment group compared with the placebo group, the mean change from baseline in body weight up to 13 weeks in the treatment group compared with placebo group, and safety and tolerability. The Phase II study enrolled 100 participants with type 2 diabetes mell","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2935737/Ascletis_Pharma_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2935737/Ascletis_Pharma_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-completes-enrollment-in-us-phase-ii-study-of-asc30-an-oral-small-molecule-glp-1r-agonist-for-the-treatment-of-diabetes-302753647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630701098","title":"Wedding Dresses Now Come With a Legal Waiver for Brides on GLP-1s -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2630701098","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630701098?lang=en_us&edition=fundamental","pubTime":"2026-04-25 17:30","pubTimestamp":1777109400,"startTime":"0","endTime":"0","summary":"When Nicole Hamilton found the A-line gown she plans to wear to her wedding reception, she requested a waist roughly 3 inches smaller than her frame.Hamilton, a product designer in New York, has lost roughly 50 pounds on weight-loss medications in the past few years -- including 15 pounds since her fiancé popped the question last May. And she plans to lose more.But when she went to buy her dress, she ran into a less-than-thrilling hurdle: She had to sign a legal waiver, acknowledging in writing that the gown didn't yet fit.Selling wedding gowns has always been a high-stakes business. But these days, outfitting brides for their big day is more fraught than ever because of GLP-1 weight-loss drugs.On average, wedding dresses cost $2,250, and can reach $10,000 or more for designer gowns, according to Zola. And while the search for the perfect dress may not be as protracted for some brides as it once was, shoppers who are spending thousands of dollars expect precision in every stitch. For d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630876725","title":"Is It Time To Reassess Global Partners (GLP) After Recent Energy Sector Coverage?","url":"https://stock-news.laohu8.com/highlight/detail?id=2630876725","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630876725?lang=en_us&edition=fundamental","pubTime":"2026-04-25 09:19","pubTimestamp":1777079967,"startTime":"0","endTime":"0","summary":"For investors considering whether Global Partners at around US$46.39 represents fair value or a potential mispricing opportunity, this article walks through what the current numbers may be indicating.\nThe stock has moved 1.4% over the past week and 2.8% over the last month, with year‑to‑date returns of 9.8% but a 4.6% decline over the past year, which can leave investors unsure how to interpret the recent price path.\nRecent coverage has focused on Global Partners' role in the energy sector...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/is-it-time-to-reassess-global-partners-glp-after-recent-ener","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/is-it-time-to-reassess-global-partners-glp-after-recent-ener","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","DCF","BK4590","BK4144","XLE","BK4585","GLP","BK4570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629216849","title":"Global Partners schedules first-quarter results conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2629216849","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629216849?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:30","pubTimestamp":1777033819,"startTime":"0","endTime":"0","summary":"Global Partners scheduled release of first-quarter 2026 financial results before market open on May 8, 2026.Investor conference call set for May 8, 2026 at 10:00 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Partners LP published the original content used to generate this news brief via Business Wire  on April 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL7p35qd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100842642","title":"Domestic Long-Acting GLP-1 Drug Tops 100 Million Yuan in First-Year Sales but Faces Deepening Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1100842642","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100842642?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:12","pubTimestamp":1777018368,"startTime":"0","endTime":"0","summary":"INNOGEN-B has become the first domestic company to commercialize a long-acting GLP-1 drug following the approval of its Esupaglutide α injection in 2025. One year later, the company released its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161","GLP","BK4144","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629233560","title":"โมเดลการดูแลแบบผสมผสานของ NOVI Health ช่วยปิดช่องว่างระหว่างผลลัพธ์การทดลองทางคลินิกกับผลลัพธ์การใช้จริงของยา GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2629233560","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629233560?lang=en_us&edition=fundamental","pubTime":"2026-04-22 23:15","pubTimestamp":1776870900,"startTime":"0","endTime":"0","summary":", 22  2569 /PRNewswire/ --  GLP-1     9%  12   15%  STEP 1. Saw Swee Hock School of Public Health  National University of Singapore   708  NOVI Optimum Plus   GLP-1 . \" GLP-1 \" . Sue-Anne Toh NOVI Health    NUS Yong Loo Lin School of Medicine  \"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/-novi-health--glp-1-302750504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629931300","title":"NOVI Health's Hybrid Care Model Closes Gap Between Clinical Trials and Real-World GLP-1 Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629931300","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629931300?lang=en_us&edition=fundamental","pubTime":"2026-04-22 11:00","pubTimestamp":1776826800,"startTime":"0","endTime":"0","summary":"An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and digital coaching in a multi-ethnic Asian population . This matched gold-standard clinical trial results, with digital coaching acting as a measurable multiplier.SINGAPORE, April 22, 2026 /PRNewswire/ -- GLP-1 medications are transforming obesity treatment, butreal-world results consistently fall short of clinical trial outcomes, which sits at around 9% at 12 months, well below the 15% reported in landmark trials like STEP 1, largely due to high discontinuation rates, suboptimal dosing, and lack of structured behavioral support.A new peer-reviewed study, published in the International Journal of Obesity , shows that NOVI Health has effectively closed that gap.The study, conducted in collaboration with the Saw Swee Hock School of Public Health at the National University of Singapore , evaluated 708 adults enrolled in NOVI Optimum Plus, a physician-led obesity ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/novi-healths-hybrid-care-model-closes-gap-between-clinical-trials-and-real-world-glp-1-outcomes-302748527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}